Online monitoring of monoclonal antibody product titers
throughout
biologics process development and production enables rapid bioprocess
decision-making and process optimization. Conventional analytical
methods, including high-performance liquid chromatography and turbidimetry,
typically require interfacing with an automated sampling system capable
of online sampling and fractionation, which suffers from increased
cost, a higher risk of failure, and a higher mechanical complexity
of the system. In this study, a novel nanofluidic system for continuous
direct (no sample preparation) IgG titer measurements was investigated.
Tumor necrosis factor α (TNF-α), conjugated with fluorophores,
was utilized as a selective binder for adalimumab in the unprocessed
cell culture supernatant. The nanofluidic device can separate the
bound complex from unbound TNF-α and selectively concentrate
the bound complex for high-sensitivity detection. Based on the fluorescence
intensity from the concentrated bound complex, a fluorescence intensity
versus titer curve can be generated, which was used to determine the
titer of samples from filtered, unpurified Chinese hamster ovary cell
cultures continuously. The system performed direct monitoring of IgG
titers with nanomolar resolution and showed a good correlation with
the biolayer interferometry assays. Furthermore, by variation of the
concentration of the indicator (TNF-α), the dynamic range of
the system can be tuned and further expanded.